Vela, the stellar constellation of the sail, is a symbol for the journey through the adventure of health. According to the motto “exploring health” of the CEO of the company, Dr. Markus Fido, VelaLabs is perceived as international partner for the pharma and biotechnology industry developing biopharmaceuticals and biosimilars.
VelaLabs offers analytical test methods for medicinal agents and drugs in the preclinical and clinical development phase. The analytical portfolio is based on the ICH-guidelines (International Conference for Harmonization) and covers non-cellular and cellular methods. The portfolio is further completed by advisory support for submission-relevant clinical studies, drug product release, competitive intelligence and biosafety.
The most important tool for assuring the quality standards of VelaLabs is the GMP certification, which represents the highest level of quality in the pharmaceutical industry. Furthermore, VelaLabs is working compliant with GCLP guidelines for all bioanalytical services.
VelaLabs stands for individual customer support, highest quality standards and professional expertise.
VelaLabs - meaningful analytics